Publikation

Health-Related Quality of Life in MONARCH 3: Abemaciclib plus an Aromatase Inhibitor as Initial Therapy in HR+, HER2- Advanced Breast Cancer

Wissenschaftlicher Artikel/Review - 24.06.2020